These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7758678)

  • 1. Mitogenic stimulation of osteoblastic cells by IGF-I is increased by synchronisation of cells in G1-phase.
    McSheehy PM; Coltro-Campi C; Grazioli V; Mena R; Soldini L; Zocchetti A; Clarke GD
    Biochem Soc Trans; 1995 Feb; 23(1):116S. PubMed ID: 7758678
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase.
    Farquharson C; Milne J; Loveridge N
    Bone Miner; 1993 Aug; 22(2):105-15. PubMed ID: 8251763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
    Zhang W; Lee JC; Kumar S; Gowen M
    J Bone Miner Res; 1999 Apr; 14(4):528-35. PubMed ID: 10234573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.
    Ernst M; Rodan GA
    Endocrinology; 1990 Aug; 127(2):807-14. PubMed ID: 2164921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10.
    Schmid C; Keller C; Gosteli-Peter M; Zapf J
    Biochem Biophys Res Commun; 1999 Oct; 263(3):786-9. PubMed ID: 10512758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts.
    Kawakami A; Nakashima T; Tsuboi M; Urayama S; Matsuoka N; Ida H; Kawabe Y; Sakai H; Migita K; Aoyagi T; Nakashima M; Maeda K; Eguchi K
    Biochem Biophys Res Commun; 1998 Jun; 247(1):46-51. PubMed ID: 9636651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of mitogenic action of aluminum ion on human bone cells: potential involvement of the insulin-like growth factor regulatory system.
    Lau KH; Utrapiromsuk S; Yoo A; Mohan S; Strong DD; Baylink DJ
    Arch Biochem Biophys; 1993 Jun; 303(2):267-73. PubMed ID: 7685579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action.
    Leung K; Rajkovic IA; Peters E; Markus I; Van Wyk JJ; Ho KK
    Endocrinology; 1996 Jul; 137(7):2694-702. PubMed ID: 8770888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
    Furlanetto RW; Harwell SE; Frick KK
    Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells.
    Pirskanen A; Jääskeläinen T; Mäenpää PH
    Eur J Biochem; 1993 Dec; 218(3):883-91. PubMed ID: 8281940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines.
    Perks CM; Gill ZP; Newcomb PV; Holly JM
    Br J Cancer; 1999 Feb; 79(5-6):701-6. PubMed ID: 10070857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daidzein inhibits insulin- or insulin-like growth factor-1-mediated signaling in cell cycle progression of Swiss 3T3 cells.
    Higashi K; Ogawara H
    Biochim Biophys Acta; 1994 Mar; 1221(1):29-35. PubMed ID: 8130274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
    Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
    Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-II receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields.
    Fitzsimmons RJ; Ryaby JT; Magee FP; Baylink DJ
    J Bone Miner Res; 1995 May; 10(5):812-9. PubMed ID: 7639117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human bone cell phenotypes differ depending on their skeletal site of origin.
    Kasperk C; Wergedal J; Strong D; Farley J; Wangerin K; Gropp H; Ziegler R; Baylink DJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2511-7. PubMed ID: 7629252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells.
    Scheven BA; Hamilton NJ; Fakkeldij TM; Duursma SA
    Growth Regul; 1991 Dec; 1(4):160-7. PubMed ID: 1842348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I.
    Giannobile WV; Whitson SW; Lynch SE
    J Dent Res; 1997 Sep; 76(9):1569-78. PubMed ID: 9294491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
    Yeh LC; Adamo ML; Olson MS; Lee JC
    Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells.
    Grey A; Chen Q; Xu X; Callon K; Cornish J
    Endocrinology; 2003 Nov; 144(11):4886-93. PubMed ID: 12960100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.